Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

RT @Coherus_Bio: 91% of physicians are open to switching to Biosimilars. Read more here: https://t.co/iHz1ZJdwU8

RT @DWComms: Hot #research topic! High lvl misunderstanding - what do you think of #biosimilars ? Provided approached ethically/robustly,…

Hot #research topic! High lvl misunderstanding - what do you think of #biosimilars ? Provided approached ethically/robustly, improved access to treatments - surely a good thing? Roll on #nocebo ! Paper here: https://t.co/kImurTfIFo @BiosimilarsBio @BritBi

RT @UK_nurseMax: https://t.co/DQuHcCNWIf @Gayleresearch @pauline_mcglone @alice_garrood @alijpot_ali

RT @UK_nurseMax: https://t.co/DQuHcCNWIf @Gayleresearch @pauline_mcglone @alice_garrood @alijpot_ali

https://t.co/DQuHcCNWIf @Gayleresearch @pauline_mcglone @alice_garrood @alijpot_ali

RT @USBiosimilars: 77% of surveyed physicians had heard the term #biosimilars in the previous month. Read more here: https://t.co/1yu0s2teq…

77% of surveyed physicians had heard the term #biosimilars in the previous month. Read more here: https://t.co/1yu0s2teqE https://t.co/ddfGYZZiwf

RT @BrianLehman1: A5: Awareness of biosimilars is high. 77% of specialty physicians had heard the term biosimilars. https://t.co/vwzMls07Xo…

RT @BrianLehman1: A5: Awareness of biosimilars is high. 77% of specialty physicians had heard the term biosimilars. https://t.co/vwzMls07Xo…

A5.2 https://t.co/ihWZV9goJh #BiosimilarsChat

A5: Awareness of biosimilars is high. 77% of specialty physicians had heard the term biosimilars. https://t.co/vwzMls07Xo #BiosimilarsChat

RT @BrianLehman1: Awareness of biosimilars is high. 77% of U.S. specialty physicians had heard the term biosimilars. https://t.co/vwzMls07…

Awareness of biosimilars is high. 77% of U.S. specialty physicians had heard the term biosimilars. https://t.co/vwzMls07Xo #BiosimilarsChat

RT @USBiosimilars: 77% of survey physicians had heard the term #biosimilars in the previous month. Read more here: https://t.co/Y6NvbtiPH8…

Survey shows 91% of physicians are open to prescribing #biosimilars: https://t.co/63k8TQj7pK

77% of survey physicians had heard the term #biosimilars in the previous month. Read more here: https://t.co/Y6NvbtiPH8 https://t.co/DQNH2QAP27

RT @USBiosimilars: 91% of physicians would consider switching a patient from an orignator biologic to a biosimilar. https://t.co/hwSADtd0Dq…

91% of physicians are open to switching to Biosimilars. Read more here: https://t.co/iHz1ZJdwU8

RT @USBiosimilars: 77% of survey physcians had heard the term #biosimilars in the previous month. Read more here: https://t.co/VMGpxjXZBJ h…

RT @USBiosimilars: 77% of survey physcians had heard the term #biosimilars in the previous month. Read more here: https://t.co/VMGpxjXZBJ h…

77% of survey physcians had heard the term #biosimilars in the previous month. Read more here: https://t.co/VMGpxjXZBJ https://t.co/nIZVc4gFFf

Awareness, Knowledge, and Perceptions of #Biosimilars Among Specialty Physicians https://t.co/bkF33BvW50 https://t.co/m7UBWuuAj5

91% of physicians would consider switching a patient from an orignator biologic to a biosimilar. https://t.co/hwSADtd0Dq https://t.co/6dowhh6by6

This survey highlights a need for evidence-based education about biosimilars for physicians across specialties. https://t.co/9GhBnaKWI2

77% of survey physcians had heard the term #biosimilars in the previous month. Read more here: https://t.co/GRRytPMSAh https://t.co/g2HIvnaaJG

RT @USBiosimilars: 77% of https://t.co/fvhl175qxz survey physcians had heard the term #biosimilars in the previous month. Read more here: h…

77% of https://t.co/fvhl175qxz survey physcians had heard the term #biosimilars in the previous month. Read more here: https://t.co/Nh842iw3ns

RT @AdisRapidPlus: How knowledgeable are physicians on #biosimilars? One of our most highlighy downloaded papers investigated: https://t.co…

RT @AdisRapidPlus: How knowledgeable are physicians on #biosimilars? One of our most highlighy downloaded papers investigated: https://t.co…

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians | https://t.co/eYLSgwlxNL https://t.co/aUpC1XCAr6

How knowledgeable are physicians on #biosimilars? One of our most highlighy downloaded papers investigated: https://t.co/dFA5UIdEnK https://t.co/eNE5oFWpuh

And awareness will remain low in the US until more than 2 products are marketed and in the hands of patients and physicians... https://t.co/wVhizWNJCs

Awareness of #biosimilars still low with physicians and patients in the US; https://t.co/5SUJ3Cipxg ($NVS funded research) https://t.co/rdchiKVvmr

RT @USBiosimilars: 77% of survey physicians had heard the term #biosimilars in the previous month. Read more here: https://t.co/axUYTwu3Ib…

RT @USBiosimilars: 77% of survey physicians had heard the term #biosimilars in the previous month. Read more here: https://t.co/axUYTwu3Ib…

77% of survey physicians had heard the term #biosimilars in the previous month. Read more here: https://t.co/axUYTwu3Ib https://t.co/nOubMdaWmp

RT @USBiosimilars: The Forum published a survey that demonstrated the need for #biosimilars education among physicians https://t.co/ScSm9Um…

RT @USBiosimilars: The Forum published a survey that demonstrated the need for #biosimilars education among physicians https://t.co/ScSm9Um…

The Forum published a survey that demonstrated the need for #biosimilars education among physicians https://t.co/ScSm9Um0cO https://t.co/aP2OhuA1Pr

RT @USBiosimilars: 77% of survey physcians had heard the term #biosimilars in the previous month. Read more here: https://t.co/GRRytPMSAh h…

77% of survey physcians had heard the term #biosimilars in the previous month. Read more here: https://t.co/GRRytPMSAh https://t.co/N3JL41LLNh

The Forum published a survey that demonstrated the need for biosimilars education among physicians https://t.co/CRNlQpKA1o https://t.co/T2E40KkBkT

RT @USBiosimilars: 77% of survey physcians had heard the term #biosimilars in the previous month. Read more here: https://t.co/GRRytPMSAh h…

RT @USBiosimilars: 77% of survey physcians had heard the term #biosimilars in the previous month. Read more here: https://t.co/GRRytPMSAh h…

RT @USBiosimilars: 77% of survey physcians had heard the term #biosimilars in the previous month. Read more here: https://t.co/GRRytPMSAh h…

RT @USBiosimilars: 77% of survey physcians had heard the term #biosimilars in the previous month. Read more here: https://t.co/GRRytPMSAh h…

77% of survey physcians had heard the term #biosimilars in the previous month. Read more here: https://t.co/GRRytPMSAh https://t.co/NkZEz4swg3

RT @USBiosimilars: Awareness of #biosimilars is high, but there are still 5 major knowledge gaps we need to address. https://t.co/CRNlQpKA1…

RT @USBiosimilars: Awareness of #biosimilars is high, but there are still 5 major knowledge gaps we need to address. https://t.co/CRNlQpKA1…

RT @USBiosimilars: Awareness of #biosimilars is high, but there are still 5 major knowledge gaps we need to address. https://t.co/CRNlQpKA1…

Awareness of #biosimilars is high, but there are still 5 major knowledge gaps we need to address. https://t.co/CRNlQpKA1o https://t.co/XMSQoFU60B

RT @USBiosimilars: Physicians who better understand #biosimilars have fewer concerns with safety + efficacy, survey results indicate https:…

RT @USBiosimilars: Physicians who better understand #biosimilars have fewer concerns with safety + efficacy, survey results indicate https:…

https://t.co/zshTWTZdY4

Physicians who better understand #biosimilars have fewer concerns with safety + efficacy, survey results indicate https://t.co/GRRytPMSAh

RT @USBiosimilars: Awareness of #biosimilars is high, but there are still 5 major knowledge gaps we need to address. https://t.co/CRNlQpKA1o

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians; https://t.co/lMyAHgHg93

RT @USBiosimilars: Awareness of #biosimilars is high, but there are still 5 major knowledge gaps we need to address. https://t.co/CRNlQpKA1o

RT @USBiosimilars: Awareness of #biosimilars is high, but there are still 5 major knowledge gaps we need to address. https://t.co/CRNlQpKA1o

RT @USBiosimilars: Awareness of #biosimilars is high, but there are still 5 major knowledge gaps we need to address. https://t.co/CRNlQpKA1o

Awareness of #biosimilars is high, but there are still 5 major knowledge gaps we need to address. https://t.co/CRNlQpKA1o

Our most highly downloaded #openaccess paper last month on #biosimilar knowledge among physicians https://t.co/m2PfcsR3CY @USBiosimilars

RT @USBiosimilars: 77% of physicians had heard the term #biosimilars in the previous month. Read more here: https://t.co/GRRytPMSAh https:/…

RT @USBiosimilars: 77% of physicians had heard the term #biosimilars in the previous month. Read more here: https://t.co/GRRytPMSAh https:/…

77% of physicians had heard the term #biosimilars in the previous month. Read more here: https://t.co/GRRytPMSAh https://t.co/gkgmfFrX2O

RT @USBiosimilars: 82% of physicians believe #biosimilars will expand treatment options. #ASH16 Click here for more info https://t.co/H1qi7…

RT @USBiosimilars: 82% of physicians believe #biosimilars will expand treatment options. #ASH16 Click here for more info https://t.co/H1qi7…

RT @USBiosimilars: 82% of physicians believe #biosimilars will expand treatment options. #ASH16 Click here for more info https://t.co/H1qi7…

Latin America develop your Biosimilars=growth, equality and independence. @vikidonda @msalnacion @Stolbizer @isagsunasur @mauriciomacri https://t.co/Fg97fNSbWp

82% of physicians believe #biosimilars will expand treatment options. #ASH16 Click here for more info https://t.co/H1qi7Hikki https://t.co/Hdeh4wqp8h

RT @medisien: @LolaPodemosEu this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutic…

A must read! Para leer! https://t.co/uqv0gtaQyR

RT @USBiosimilars: Do you know how many physicians would consider switching their patients to #biosimilars? #ASH16 Find out here. https://t…

@MinSaludCol this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@gracielaocana this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests https://t.co/JZEWeWtydV

RT @medisien: @LolaPodemosEu this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutic…

@MinisteriodeSa1 this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@LolaPodemosEu this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@isagsunasurthis is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@SSSALUD this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@vikidondathis is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@SaludMisiones this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@GugaLustothis is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@Stolbizer this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@RegaCarlosthis is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@GremialMedicathis is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@PAMI_org_ar this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@mauriciomacri this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@msalnacion this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

@SergioMassa this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

Latin America this is the way to https://t.co/pwx6JtE6OB money and use it for other priorities.Don't give up to pharmaceutical interests. https://t.co/JZEWeWtydV

RT @USBiosimilars: Do you know how many physicians would consider switching their patients to #biosimilars? #ASH16 Find out here. https://t…

Do you know how many physicians would consider switching their patients to #biosimilars? #ASH16 Find out here. https://t.co/GRRytPMSAh https://t.co/9SssaUgWzF

RT @USBiosimilars: Looking for highlights on our physician survey? This infographic shows where #biosimilar education is most needed https:…

RT @USBiosimilars: Looking for highlights on our physician survey? This infographic shows where #biosimilar education is most needed https:…

RT @USBiosimilars: We published a survey in Nov. on awareness + perception of #biosimilars among US physicians. Read the article here https…

We published a survey in Nov. on awareness + perception of #biosimilars among US physicians. Read the article here https://t.co/GRRytPMSAh

Bio what? https://t.co/BaUlMxjDk0 #brccast102 https://t.co/AhkqLHfcY9

RT @USBiosimilars: Looking for highlights on our physician survey? This infographic shows where #biosimilar education is most needed https:…